Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quxie Capsule to Reduce Postoperative Recurrence and Metastasis in Colorectal Cancer
ChiCTR2000039015Phase 4Completed
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Quxie capsule in colorectal cancer (CRC) (2 arms), sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences. Primary endpoints: 5-year survival rate, 10-year survival rate and 2 more. Started Nov 2020; status: completed.
02
Drugs
Quxie capsule
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000039015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039015.